Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

22
www.zmcp.org OPERATIONAL RESEARCH PRIORITIES FOR MANAGING FEBRILE ILLNESS op Shija Joseph Shija AMFm Coordinator Zanzibar Malaria Control Programme (ZMCP) The National Academies, 2101 Constitution Avenue NW, Washington, DC 20037 September 17-18/2012

description

http://cddep.org/sites/default/files/presentation-iom_amfm_meeting_zanzibar_or_priorities_for_managing_febrile_illness-1_0.pdf

Transcript of Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

Page 1: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

OPERATIONAL RESEARCH PRIORITIES FOR MANAGING FEBRILE ILLNESS

op

Shija Joseph Shija AMFm Coordinator

Zanzibar Malaria Control Programme (ZMCP)

The National Academies, 2101 Constitution Avenue NW, Washington, DC 20037

September 17-18/2012

Page 2: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Background

v  Before year 2000 Zanzibar was experiencing

malaria Prevalence > 30-40% in OPD and Malaria accounted for > 50% of admitted cases,

v  Two earlier attempts to eliminate the disease were not successful and high resurgence occurred once intervention were stopped.

v  These engaged traditional control measures

Page 3: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Integrated Strategies used by ZMCP

Major interventions: •  Malaria Case management using ACTs accompanied by

improved malaria diagnosis methodologies (RDTs + Microscopes)

•  Vector control (ITN/LLITN and IRS) •  Malaria in pregnancy •  Malaria advocacy (IEC/BCC) Supportive interventions: •  SM&E •  Environmental Management •  Operational Research

Page 4: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Malaria Case Management Objective: Improve early recognition and

effective treatment of malaria cases at all health care facilities in Zanzibar

•  Screening before treatment (microscopy or Rapid Diagnostic Test)

•  Treatment of malaria by using ACTs (Amodiaquine + Artesunate)- 1st Line

•  Artemether-Lumefantrine (Coartem)-Alternative medicine.

•  Quinine- For severe malaria/Artesunate Inject.

Page 5: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Malaria Vector Control

Page 6: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Malaria Vector Control

•  Indoor Residual Spraying (IRS) in all eligible houses

Page 7: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Vector Control

•  Objective: Increase household ownership

and use of ITNs among the general population in all districts of Zanzibar

•  Percentage of children under five sleeping under treated nets

•  Percentage of pregnant women sleeping under treated net

•  Percentage of general population sleeping under treated net

Page 8: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Prevention of malaria during pregnancy

Comprises of three main interventions 1.  Intermittent Preventive Therapy 2.  Malaria case management in pregnancy 3.  Use of Insecticide Treated nets during

pregnancy Other maternal care: HIV testing and pregnancy monitoring. Pregnant are most likely to harbor malaria parasites without showing

signs and symptoms •  Most vulnerable due to weak immune system •  Malaria affects both

–  Unborn baby and mother

Page 9: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Behavioural Change Communication

for MALARIA CONTROL

•  To increase understanding about Malaria, its causes, recognition of signs and symptoms, treatment control and prevention.

•  Mass media •  Community groups •  Malaria in School •  NGOs involvement

Page 10: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Supportive Interventions

SURVEILLANCE, MONITORING AND EVALUATION Zanzibar Malaria Epidemic Early Detection System (MEEDS)

disease trends morbidity and mortality

Page 11: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

MEEDS System in Zanzibar – 142 Gvt HFs

Page 12: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

 Zanzibar’s  recent  and  marked  decrease  in  malaria  prevalence    posi4ons  it  as  uniquely  hypoendemic  among  the  AMFm  pilot    

countries Positivity Rates: Zanzibar Malaria

Early Epidemic Detection System Epidemiology

•  After IRS, LLIN, and ACT interventions in 2004, parasite prevalence fell from 25% in

2003 to less than 1% in 2010 (THMIS 2008)

•  Parasite prevalence is 0.8%, ranging from 0% in Stone Town to 3.7% in northern

Pemba (THMIS 2008)

Path to Elimination

•  Political will for elimination by 2015 •  ZMCP target: 100% of malaria cases to

be confirmed by RDT or microscopy by 2014

•  Patients access diagnosis and treatment free in public sector facilities since 2007

Source: ZMCP –MEEDS SYSTEM

Page 13: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

   

AMFm  highlighted  exis4ng  issue  of  a  private  sector  with  limited    diagnos4c  capacity  and  high  an4-­‐malarial  sales  

Private Sector Landscape

•  26% of people seeking treatment for fever use the private sector (ZMCP,

2010)

•  Zanzibar’s 1LB sold ~150,000 doses of ACTm into the private

sector market from June-Dec 2011 (CHAI analysis, 2012)

31%

36%

78%

3.5% 0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

Public HF (N=139) Private HF (N=171)

Microscopy

mRDTs

Availability of Diagnostics by Sector

AMFm Phase I Independent Evaluation Outlet Survey (Baseline – 2010)

Page 14: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

   

Zanzibar  demonstrated  important  progress  on  key    AMFm  benchmarks,  but  needs  to  address  a  lack  of  diagnos4c  

 capacity  in  a  low  endemic  environment   •  Goal:    To  ensure  all  people  with  malaria  receive  &  use  a  complete  dose  of  ACT.  

9%

80%

30%

1% 0%

20%

40%

60%

80%

100%

Baseline Endline

Quality-Assured ACTs

Oral Artemisinin Monotherapies

Availability

Affordability

Market Share Market  share  of  quality-­‐assured  ACTs  increased    from  2%  to  61%  in  private  for-­‐profit  outlets  

5.99

1.17

0

2

4

6

8

Baseline Endline

(AMFm  Independent  EvaluaFon,  2012)  

Page 15: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

The AMFm operational research explores shifting to diagnostics as an exit strategy from subsidized drugs in a context of high treatment seeking behavior in the private sector

Horizon 1 Horizon 3 Horizon 2

Pre

vale

nce

High

Low

Subsidize ACTs

Regulate the private sector market

Subsidize RDTs & remove ACT from

OTC

Zanzibar Today

Key Outcomes

•  Affordable ACTs available throughout

the private sector

•  Market for sub-optimal treatments eliminated

•  Total anti-malarial market size reduced

•  ACT targeting to true malaria cases with RDTs

Page 16: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

The  AMFm  opera4onal  research  targets  ACTs  to  confirmed  cases  by  leveraging  the  private  sector  supply  chain  to  roll  out  diagnos4cs,  

 supported  by  strong  regula4on

Wholesaler

Dispensary Pharmacy Hospital, Clinic OTC

Consumer

Diagnosis Treatment Treatment

Landscape pre-intervention:

•  Large anti-malarial sales volume •  Minor RDT market •  Lack of regulation enables clinical diagnosis, presumptive self-treatment

Page 17: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

                             Use  a  structural  interven4on  to  shiJ  supply-­‐side          and  demand-­‐side  dynamics  of  malaria  case  management    toward                                                                        diagnosis  in  the  private  sector    

Intervention:

•  Distribute subsidized RDTs through private sector supply chain •  Remove anti-malarials from OTCs •  ACTs: enforce prescription-only status

Wholesaler

Dispensary Pharmacy Hospital, Clinic OTC

Consumer

RDTs RDTs

Page 18: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

 The  interven4on  aims  to  target  ACTs  to  confirmed  cases  by    leveraging    the  private  sector  supply  chain,  supported  by    

strong  regula4on

Izmir Pharmacy: AMFm First Line Buyer •  Roll out subsidized RDTs in private health facilities

•  Distribute using the AMFm First Line Buyer and private supply chain

•  Recommended retail price of 500 TZS ($.32)

Zanzibar Food and Drugs Board (ZFDB) & Zanzibar Malaria Control Program (ZMCP) •  Remove all anti-malarials from over-the-counter

(OTC) shops through a series of inspections

•  Enforce ACTs as Prescription Only Medicines

Rollout of RDTs

Regulatory Support

Page 19: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

 DIRECTION:  Zanzibar’s  approach  to  channel  malaria  cases  toward    facili4es  with  diagnosis  will  inform  other  countries  experiencing  

 a  reduc4on  in  malaria  endemicity  

April 2012 May 2012 September 2012 March 2013

Midline Evaluation

Midline Evaluation

Potential Endline

Evaluation

Gather baseline data on diagnostic availability in the Zanzibar private sector and treatment

seeking for fever illness

Launch pilot to better target anti-malarial

treatment: •  Introduce subsidized

RDTs in private HFs •  Limit access to

antimalarial

Conduct follow-up evaluation (midline, Endline) to assess impact of intervention

Page 20: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

   

Process    EvaluaFon  –  Key  quesFons  explored  

   Are  an4-­‐malarials  effec4vely  removed  from  OTC  shops?            

                   Are  RDTs  available  in  private  facili4es  and  sold  at  the  recommended                                retail  price?  

 

RESULTS  EXPECTED:  NOVEMBER  2012  

2  

1  

Page 21: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

   

Impact  EvaluaFon  –  Key  quesFons  explored  

 Is  there  an  change  in  the  propor4on  of  febrile  pa4ents  receiving  a  malaria  diagnosis?  

     

 Does  treatment  seeking  shiJ  from  the  informal  retail  sector  to    facili4es  with  diagnos4c  capacity?  

     

 

RESULTS  EXPECTED:  NOVEMBER  2012  

2  

1  

Page 22: Presentation iom amfm meeting zanzibar or priorities for managing febrile illness 1 0

www.zmcp.org

Thank you

SAVING  LIVES:  BUYING  TIME  IS  POSSIBLE  

LET  US  WORK  TOGETHER